
Review
Jul 19, 2026Ars Technica
AI in Prior Authorization: A Mixed Prognosis
AI in prior authorization offers theoretical efficiency but faces strong criticism for potentially increasing wrongful denials and patient harm. While programs like WISeR aim to cut waste, concerns persist about transparency, profit incentives, and the automation of an already flawed system, suggesting a mixed prognosis.
Read →